CCXI
13Bull0Bear7Mention
Serenity @aleabitoreddit
Focused on AI photonics and semiconductor supply chains — sourcing asymmetric setups from bottoms-up value-chain research. Tracks CPO & optical modules closely, with ongoing deep-dives on SIVE, AAOI, LITE, POET.
Quick verdict
CCXI is net bullish (13 bull · 0 bear)
A recent, one-off humanoid robotics play, currently held from an earlier purchase.
Last spoke: 08/20/2026, 09:57 · conviction 6/10
8-10 confidence views use larger markers▲ Bull▼ Bear● Mention
View History (20, newest first)
- @EnamelEquity Nope, all my thematic baskets were picked earlier this year with memory like $EWY and CPO like $SIVE. Only recent was kinda humanoids with $CCXI, but that's one-off. I'm just waiting for everything to play out, not a fan of jumping ship to ship.
- Unitree (688836) is now public. And is valued at ~$53.3B, after rising +492.18% We finally have a major public company benchmark for humanoids. For reference, Agility (backed by $NVDA, $AMZN) via $CCXI is expected to go public at $2.5B premoney valuation Q4. $TSLA is $1T+, but Optimus is wrapped inside a much larger company. But I think Unitree showed that the demand for pure play humanoid players is much larger… than people expected in public markets.
- @tRbW6qAUT717891 I can't buy A-Shares, so I'm sticking with US markets. Agility via $CCXI( $NVDA, $AMZN, Softbank backed) is my personal exposure to humanoids. But I'm cheering on everyone who won the lottery for Unitree shares.
- @AZAAC6 $CCXI name changes into Agility sometime in October at the earliest. So maybe 2 months from now. Officially it's Q4.
- As for names Jensen / Nvidia directly invested in: - $MRVL (Celestial), $LITE, $COHR for photonics... - $CCXI (Agility) for humanoids. I tend to do more complex investing, for my own thought process: -> I know CPO theme is coming next -> Nvidia secures all CW laser capacity. -> Maybe, $AAOI, $MTSI, $AVGO, $SIVE, $SMTC are remaining CW western players. -> $SIVE probably the highest-beta exposure. SO that was my personal long. Can probably do something similar for the other themes.
- uhhh... the Unitree IPO is more than 8000 times oversubscribed by retail investors. The demand for pure play humanoid companies is absolutely enormous? I'm personally in the US-based Agility Robotics club (Softbank, $NVDA, $AMZN, Foxconn, etc), at $2.5B premoney via $CCXI. And my take is that Unitree likely opening at $30B+ (from pre-ipo perps), might bring the leading US players some more attention in a week or two. Regardless that's just absurd demand.
- Just some near term events: - OCP APAC tomorrow (Ayar, Lightmatter, $AMD, $NVDA) and your CPO players are giving announcements/updates. This should be a catalyst for certain optical players. - Earnings week: with $ASTS, $RKLB reporting today (space), $LITE on Tuesday (photonics), $NBIS in the middle of the week (Neocloud), and more. - Unitree IPO subscriptions opened up today and Listing is expected this month. Should be a potential catalyst for the humanoid + robotics sector if it opens up well eg. $CCXI. Fun week ahead.
- Unitree is being listed this month, and is expected to open around a $30B valuation (pre-IPO perps) from ~$5.6B -> $9B now. Given Agility is valued at $2.5B premoney with $CCXI, I’m just watching what happens to the robotics sector and especially Agility, when Unitree goes public. I’ve already laid down my thesis with humanoids and I’m personally waiting for it to play out.
- Let’s put it this way: Retail thinks a 30-60% drop is a “falling knife” where bagholders will never recover. And they end up panic selling after seeing swiggly line TAs and people comparing valuable chokepoints to memes. I see it as long term ownership over: - the next hyperscaler with $NBIS, projecting $7-9B ARR Q4 - 40% of the InP supply chain with $AXTI - leader of the next optical shift with $SIVE with CW DFB lasers - leader of US humanoids with $CCXI inside a future trillion dollar theme And so on… At cheaper valuations. While I might do things like lowering margin or hedging with my own portfolio, I’m personally not panicking when something drops if the thesis didn’t change. NFA and obviously depends on people’s investing timeframes: Since a crash would be life changing for people that depend on investing for rent or tuition. (Which is why I personally think others should do their own DD and choose longs in line with their own risk profile) But my personal goal is maximizing exposure to the next-gen supercycles before they hit. I think institutions think the same way as well, which is why there’s a lot of induced volatility along the way to maximize their exposure. If a thesis ends up correct, the valuation should be reflected in the long run.
- Literally just Elon. - The guy + $SPCX is basically the only reason why US is in the lead with Space. - $TSLA led EV commercialization in US He's sometimes off with timeframes, but right directionally, so pretty sure he can make US robotics #1 again. I personally own $CCXI though since I think Agility currently has more pure play exposure for mass production/commercialization through US supply chains + $MELI/ $AMZN.
- It’s interesting to witness psychology around valuation anchoring + scarcity. Retail, for example, are buying Figure, last valued at ~$39B through CEFs… At $158B, since it’s private, round 4x valuations. Then Agility Robotics $CCXI, which has broader commercialization. Is at ~$4.3B pre-money and publicly available before the name change. At closer pricing that $AMZN, $NVDA, SoftBank, and Foxconn vaulted it at. Yet some end up paying 4-5x prices of already hiked private investor rounds for exposure… I’m convinced if Agility raised a very small private round at $39B as well from $2.5B (which it definitely could), to set a valuation anchor. Investors would be foaming in the mouth for a private allocation, just due to psychology rather than underlying fundamentals. We’ve also seen this anchoring with $SPCX recently at $1.75T. Peak market inefficiency? Or lack of knowledge from retail?
- @haybee940 Yep, we finally have the brain with OpenAi/Anthropic breakthroughs. Now it’s time for robots (which have been backflipping for the past 10 years) like Boston Dynamics / $CCXI to come to life.
- @ontrialperiod when global and US markets crash off misinformation and out of context quotes from $META. I probably want to clear that up? That thing said, $AAOI, $SIVE, and $CCXI do make up large concentration in my portfolio.
- Just this hour: BlueCrest Capital Management and its Billionaire Michael Platt crossed the threshold and disclosed a 5.6% stake in $CCXI. I knew Agility Robotics would be popular… https://t.co/n7bqpmCykd
- @SUOHA_AI I remember first investing in $RKLB back at $15 or so. It just find it rare to get exposure to a downstream + frontier sector leader. So I’m personally not missing this chance again with $CCXI.
- Agility Robotics is literally the #1 humanoid player in the US in terms of commercialization today imo. Personal Rankings: 1. Agility Robotics via $CCXI 2. $TSLA Optimus ($1T+ company) 3. Figure at $39B from 2025, likely higher now. With Tesla likely taking the lead a year from now. So at $16, you have a ~$4B MC pre-money humanoid player. Which is already inside $AMZN and $MELI (ideal use cases to start out, before step-functioning to general-use), with $AMZN, $NVDA, Softbank, Foxconn, and others as investors. NFA, but at those valuations... there's direct exposure for the first ever humanoid player today, that's likely further ahead than Figure for commercialization. No hard feelings about Robostrategy, but it's over 4x+ NAV: Which would value Figure at $156B... While there's the #1 commercialized humanoid player with Agility at $4B today. So my personal preference is $CCXI.
- I’m personally long $CCXI and have highest concentration in Agility Robotics (NFA). It’s currently around a ~$4.9B valuation. Figure’s last round was $39B last year, and that was before the increasing interest in humanoids/robotics this year. Then a large part of $TSLA $1T+ valuations come from humanoids. I like companies like LeaderDrive… but usually the downstream players capture the most value in the end. And I find it rare to see one that has public exposure early on.
- Just a random thought, leading US humanoid players strangely me of the current LLM dynamics: Agility ( $CCXI ) kinda feels like Anthropic for robotics. With $AMZN and $NVDA heavily backing it, ingrained with $GOOGL Deepmind (like TPUs). And it starts off with enterprise commercialization. Optimus is kinda off doing its own thing like xAI. Supported by Tesla/Elon and his visionary roadmap as usual. Figure is like ChatGPT With Microsoft/OpenAI investing (kinda like Microsoft), then ended up kinda competing them by building their own VlA and setting them behind. But ends up top 2 leaders anyway. Boston Dynamics is Gemini Kinda started the entire humanoids thing like transformers with backflip videos. With R&D supported by $GOOGL but somehow let everyone else leapfrog them in commercialization. And then there’s $NVDA just chilling, silently powering the entire humanoids ecosystem.
- @AleksandarGenov Probably Agility Robotics going public with $CCXI and all the media narratives around it was the catalyst. Feels like $OUST, $AEVA and other names were pretty flat until the announcement. As for energy like $FCEL, $BE, seems pretty fundamental with new upsized contracts
- Yep! Agility Robotics is currently my favorite humanoid/robotics position. They're set to be listed on NASDAQ via $CCXI as early as September (per Digitimes). Just for informational purposes: Their V4 humanoid robot is already operating in sites like Amazon. And have V5 slated for mass production next year (they have a 10,000+ /year capacity). Investors include Foxconn, $NVDA, $AMZN, Softbank, and now Serenity. I've been personally waiting for humanoid exposure for awhile (Agility is set to be the first US pure-play listed one) to the point I was actually planning on investing in Unitree's IPO. But I'm glad now I personally have a compelling alternative now since I prefer to invest capital to build up Made in America supply chains (75% of their components are US-sourced from investor desks). There are risks assigned to SPACs such as listing delays, or cancellation. But excited to see what happens next with developments. I do hope this encourages other frontier companies to go public early on.
Ongoing takes on other optical names too
Beyond CCXI, his viewpoint library also covers: